MODIFIZIERTE VASOAKTIVE DARMPEPTIDE

Patent europeic · EP3311828 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3311828
Numer da la dumonda
EP17163446
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-08-2010
Publitgà
25-04-2018
Concedì
07-04-2021
La protecziun finescha il pli tard
15-08-2030
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 38/00 (2006.01)
A61K 38/24 (2006.01)
A61P 37/00 (2006.01)
A61P 9/00 (2006.01)
A61P 9/12 (2006.01)
Prioritad
US 234151 P 14.08.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 01-09-2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. 03-09-2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 03.09.2024

  4. 01-09-2023

    Midada

    Published in Swissreg on 01.09.2023

  5. 06-09-2022

    Midada

    Published in Swissreg on 06.09.2022

  6. 16-02-2022

    Midada

    Published in Swissreg on 16.02.2022

  7. 07-04-2021

    Concedì

    Published in Swissreg on 07.04.2021

Partidas

Possessur

Phasebio Pharmaceuticals, Inc.

One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355, US

Inventur

DAGHER, Suzanne

Malvern, Pennsylvania 19355, US

SADEGHI, Homayoun

Malvern, Pennsylvania 19355, US

TURNER, Andrew

Malvern, Pennsylvania 19355, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.